1. Home
  2. CAVA vs HALO Comparison

CAVA vs HALO Comparison

Compare CAVA & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$72.99

Market Cap

9.2B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$71.61

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAVA
HALO
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
8.8B
IPO Year
2023
2001

Fundamental Metrics

Financial Performance
Metric
CAVA
HALO
Price
$72.99
$71.61
Analyst Decision
Buy
Buy
Analyst Count
23
11
Target Price
$91.00
$78.64
AVG Volume (30 Days)
3.3M
1.8M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
1.22
Revenue
$1,179,664,000.00
$151,862,000.00
Revenue This Year
$25.71
$28.24
Revenue Next Year
$20.57
$12.56
P/E Ratio
$360.60
$58.69
Revenue Growth
22.41
N/A
52 Week Low
$43.41
$51.06
52 Week High
$98.79
$82.22

Technical Indicators

Market Signals
Indicator
CAVA
HALO
Relative Strength Index (RSI) 36.15 60.66
Support Level $60.54 $67.94
Resistance Level $72.93 $74.58
Average True Range (ATR) 3.94 2.03
MACD -0.62 0.27
Stochastic Oscillator 16.34 86.63

Price Performance

Historical Comparison
CAVA
HALO

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: